Pharmacists in Swampscott, Massachusetts


13 Pharmacists found in Swampscott
male pharmacist

Alan Leonard Kramer


Pharmacist
450 Paradise Rd, Swampscott, MA 01907
781-596-0224    

female pharmacist

Alana Desimone


Pharmacist
413 Paradise Rd, Swampscott, MA 01907
781-595-8588    

female pharmacist

Ashley Macdougall, PHARMD


Pharmacist
450 Paradise Rd, Swampscott, MA 01907
781-596-0224     781-596-2311



female pharmacist

Donna Elayne Wholley, RPH


Pharmacist
450 Paradise Rd, Swampscott, MA 01907
781-596-0224     781-596-2311

male pharmacist

Dr. Dutrochet Djoko, PHARMD


Pharmacist
413 Paradise Rd, Swampscott, MA 01907
781-595-8588    

male pharmacist

Dr. Fred Hyyoot


Pharmacist
1006 Paradise Rd Apt 3d, Swampscott, MA 01907
617-306-8785    

male pharmacist

Gene Pelikhov, PHARMD


Pharmacist
413 Paradise Rd, Swampscott, MA 01907
781-595-8588    

female pharmacist

Liliya Podradchik


Pharmacist
6 Atlantic Xing, Swampscott, MA 01907
617-257-0674    

female pharmacist

Oanh Duong


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
413 Paradise Rd, Swampscott, MA 01907
978-968-8072    

male pharmacist

Mr. Peter N Pappas


Pharmacist
450 Paradise Rd, Swampscott, MA 01907
781-581-1327     781-596-3728

female pharmacist

Dr. Vanessa Frempong, PHARMD


Pharmacist
413 Paradise Rd, Swampscott, MA 01907
781-595-8588    

female pharmacist

Vickie Thi Vo


Pharmacist
505 Paradise Rd, Swampscott, MA 01907
781-581-1327    

female pharmacist

Dr. Viviane Nogarotto I


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
413 Paradise Rd, Swampscott, MA 01907
781-595-8588    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.